




Searching News Database: RECORDATI
HSMN NewsFeed - 18 Jan 2017
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Mexico
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Mexico
HSMN NewsFeed - 18 Nov 2016
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
HSMN NewsFeed - 21 Jun 2016
Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement
Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement
HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
HSMN NewsFeed - 7 Apr 2010
Recordati Signs Co-Marketing Agreement With Esteve in Spain for Pitavastatin
Recordati Signs Co-Marketing Agreement With Esteve in Spain for Pitavastatin
HSMN NewsFeed - 16 Jan 2008
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
HSMN NewsFeed - 1 Oct 2007
Recordati Acquires Orphan Europe, a European Group Specialized in Rare Diseases
Recordati Acquires Orphan Europe, a European Group Specialized in Rare Diseases
HSMN NewsFeed - 9 Jan 2007
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
Additional items found! 4

Members Archive contains
4 additional stories matching:
RECORDATI
(Password required)
RECORDATI
(Password required)